本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Inhibikase Therapeutics, Inc.

2.31
0.0000
成交量:27.50萬
成交額:63.84萬
市值:3.23億
市盈率:-5.34
高:2.37
開:2.31
低:2.30
收:2.31
52周最高:2.61
52周最低:1.33
股本:1.40億
流通股本:6,452.05萬
量比:1.31
換手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-0.4327
每股收益(LYR):-0.4909
淨資產收益率:-51.96%
總資產收益率:-32.79%
市淨率:2.11
市盈率(LYR):-4.71

資料載入中...

2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/27

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/07/31

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/23

重要事件披露

Form 8-K - Current report
2026/07/17

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/14

重要事件披露

Form 8-K - Current report
2026/06/29

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]